As the U.S. grapples with the deadly opioid epidemic and public outrage over drug costs, an accreditor of medical affairs professionals and pharmaceutical sales representatives is grabbing the attention of politicians and policymakers.
Christine Megalla, Pharm.D., Associate Director of Educational Programs at the Accreditation Council for Medical Affairs, talks about the organization’s certification process.
“There’s a huge lack of training and education that prepare people to go into the biopharmaceutical space,” said Dr. Sotirios Stergiopoulos, chief medical officer and head of global medical affairs at Ipsen. “Based on the current circumstances it’s a very opportune time to say, ‘Hey, there’s a way to do things responsibly.’” …. Read More